Status:
UNKNOWN
Low Dose Aspirin for the Prevention of Preeclampsia
Lead Sponsor:
Saint Thomas Hospital, Panama
Conditions:
Preeclampsia
Eligibility:
FEMALE
Phase:
PHASE3
Brief Summary
Preeclampsia is one of the three leading causes of maternal morbidity and mortality all over the world. The use of low dose aspirin has been mentioned in several studies with promising results. The in...
Eligibility Criteria
Inclusion
- Gestational age between 13 and 16 weeks of pregnancy
- High risk of preeclampsia, based in clinical risk factors as:
- Preeclampsia in a previous pregnancy Mother or sister that developed preeclampsia in a previous pregnancy Diabetes Mellitus (insulin dependant) Chronic Hypertension (with/without proteinuria) Body Mass Index \> 32 Multiple pregnancy Lupus or other autoimmune disorder Chronic Renal Disease.
Exclusion
- Blood coagulation disorders of any kind
- Peptic ulcers
- Allergy to aspirin
- Chronic use of anti-inflammatory drugs
- Fetus with mayor anomalies
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
476 Patients enrolled
Trial Details
Trial ID
NCT01890005
Start Date
July 1 2013
End Date
January 1 2014
Last Update
July 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Thomas Maternity Hospital
Panama City, Panama